Why Is Cyclopentolate So Hard to Find? [Explained for 2026]

If Your Eye Doctor Can't Get Cyclopentolate, You're Not Alone

You went in for an eye exam — maybe a routine check-up, maybe your child's first visit to the ophthalmologist — and heard something unexpected: "We're having trouble getting Cyclopentolate right now." If that happened to you, you're far from alone. Cyclopentolate, one of the most commonly used eye drops for dilating pupils during exams, has been in short supply across the United States. The shortage has frustrated patients, parents, and eye care providers alike.

In this article, we'll explain what Cyclopentolate is, why it's become so hard to find in 2026, and what steps you can take if your provider or pharmacy is out of stock.

What Is Cyclopentolate?

Cyclopentolate (brand name Cyclogyl) is an anticholinergic eye drop used to dilate your pupils and temporarily paralyze the focusing muscles in your eyes. This process — called mydriasis and cycloplegia — is essential for thorough eye examinations, especially for children who need accurate refraction measurements for glasses prescriptions.

The medication comes as an ophthalmic solution in three strengths: 0.5%, 1%, and 2%. It works quickly, typically within 15 to 30 minutes, and its effects last about 24 hours. Cyclopentolate is a prescription medication that is usually administered directly in the eye doctor's office, though some patients fill prescriptions at retail pharmacies.

For a deeper look at how this medication works in the body, check out our article on how Cyclopentolate works.

Why Is Cyclopentolate So Hard to Find in 2026?

The Cyclopentolate shortage isn't caused by a single problem — it's the result of several factors hitting at the same time. Here are the main reasons this medication has become scarce.

1. A Major Manufacturer Went Out of Business

Akorn, one of the largest generic ophthalmic drug manufacturers in the United States, filed for bankruptcy and ceased operations in 2023. Akorn produced a significant share of the country's generic Cyclopentolate supply. When they shut down, that production capacity didn't just transfer overnight to other companies. The gap in supply has persisted into 2026.

2. Limited Number of Manufacturers

Even before Akorn's closure, only a handful of companies made Cyclopentolate. Currently, Alcon (which makes the brand-name Cyclogyl) and Sandoz are among the remaining suppliers. With fewer manufacturers sharing the full burden of demand, any disruption — a quality issue, a raw material delay, a production line shutdown — can trigger a shortage.

3. Ophthalmic Drug Manufacturing Is Complex

Eye drops must meet extremely strict sterility standards because they go directly into the eye. Manufacturing ophthalmic solutions requires specialized facilities and rigorous quality control. This makes it harder for new manufacturers to enter the market quickly, even when demand is high.

4. Supply Chain Disruptions

Like many medications, Cyclopentolate relies on a global supply chain for active pharmaceutical ingredients and packaging materials. Disruptions at any point in this chain — from raw material sourcing to final bottling — can slow production and reduce the amount of product reaching pharmacies and clinics.

For the latest on the shortage situation, see our Cyclopentolate shortage update for 2026.

What You Can Do If You Can't Find Cyclopentolate

If your eye doctor's office is out of Cyclopentolate or your pharmacy can't fill a prescription, here are some practical steps you can take.

Ask Your Eye Doctor About Alternatives

Several other medications can dilate pupils and provide cycloplegia for eye exams. Tropicamide is the most common substitute — it has a shorter duration (4 to 8 hours vs. 24 hours) and slightly weaker cycloplegic effect, but works well for many patients. Atropine eye drops provide stronger, longer-lasting effects and may be used when complete cycloplegia is essential. Your doctor can determine the best option for your specific situation. Learn more in our guide to alternatives to Cyclopentolate.

Try Independent or Compounding Pharmacies

Large chain pharmacies often face the brunt of drug shortages because they order from the same major distributors. Independent pharmacies and compounding pharmacies may have access to different supply channels. Some compounding pharmacies, like Pine Pharmaceuticals, have reported having combination ophthalmic drops (such as TPC Drops containing Tropicamide, Phenylephrine, and Cyclopentolate) available even during the shortage.

Use Medfinder to Check Stock

Instead of calling pharmacy after pharmacy, you can use Medfinder to search for Cyclopentolate availability near you. Medfinder checks stock across multiple pharmacies in your area so you can find what you need faster. Read our detailed tips in how to find Cyclopentolate in stock near you.

Plan Ahead for Appointments

If you have an upcoming eye exam, call ahead to confirm your provider has the drops they need. If they don't, ask whether they can reschedule or use an alternative. Planning ahead can save you a wasted trip and help the office manage their limited supply.

Final Thoughts

The Cyclopentolate shortage is a real problem, but it's not one without solutions. Understanding why the shortage exists can help you have informed conversations with your eye care provider. Whether it's switching to an alternative like Tropicamide, finding a compounding pharmacy, or using tools like Medfinder to locate stock, there are steps you can take to make sure your eye care doesn't get put on hold.

If you're also concerned about costs, check out our guide on how to save money on Cyclopentolate in 2026.